⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9344374 | 0.65 | — | — | |
| SCHEMBL29603314 | 0.61 | — | — | |
| SCHEMBL29637355 | 0.60 | — | — | |
| SCHEMBL5927683 | 0.60 | — | — | |
| SCHEMBL15392664 | 0.59 | — | — | |
| SCHEMBL25381214 | 0.58 | — | — | |
| SCHEMBL8768416 | 0.56 | CTRB1 (0.33) | — | |
| SCHEMBL9940905 | 0.56 | — | — | |
| SCHEMBL8132713 | 0.54 | — | — | |
| SCHEMBL785508 | 0.54 | CTRB1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6943182-B2 | Cyclopentabenzofuran derivatives and their use | BAYER AKTIENGESELLSCHAFT (DE) | 2005-09-13 | — | — | US | claimed |
| US-20030144334-A1 | Cyclopentabenzofuran derivatives and their use | GUARNIERI WALTER (DE) | 2003-07-31 | — | — | US | claimed |
| EP-1102761-B1 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | BAYER AG (DE) | 2003-01-29 | — | — | EP | claimed |
| EP-1102761-A2 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | Bayer Aktiengesellschaft (DE) | 2001-05-30 | — | — | EP | claimed |
| WO-2000008007-A2 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | BAYER AKTIENGESELLSCHAFT (DE) | 2000-02-17 | — | — | WO | claimed |
| US-6943182-B2 | Cyclopentabenzofuran derivatives and their use | BAYER AKTIENGESELLSCHAFT (DE) | 2005-09-13 | — | — | US | disclosed |
| US-20030144334-A1 | Cyclopentabenzofuran derivatives and their use | GUARNIERI WALTER (DE) | 2003-07-31 | — | — | US | disclosed |
| EP-1102761-B1 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | BAYER AG (DE) | 2003-01-29 | — | — | EP | disclosed |
| US-6420393-B1 | NUCLEAR FACTOR .KAPPA.B-DEPENDENT DISEASE SELECTED FROM THE GROUP CONSISTING OF INFLAMMATORY DISEASES, IMMUNOLOGICAL DISORDERS, SEPTIC SHOCK, TRANSPLANT REJECTION, RADIATION DAMAGE, REPERFUSION INJURIES AFTER ISCHEMIA, STROKE OR | BAYER AKTIENGESELLSCHAFT (DE) | 2002-07-16 | — | — | US | disclosed |
| EP-1102761-A2 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | Bayer Aktiengesellschaft (DE) | 2001-05-30 | — | — | EP | disclosed |
| WO-2000008007-A2 | CYCLOPENTABENZOFURAN DERIVATIVES AND THEIR USE | BAYER AKTIENGESELLSCHAFT (DE) | 2000-02-17 | — | — | WO | disclosed |